Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Dec;101(4):839–842. doi: 10.1111/j.1476-5381.1990.tb14167.x

Differential effects of chronic lorazepam and alprazolam on benzodiazepine binding and GABAA-receptor function.

W R Galpern 1, L G Miller 1, D J Greenblatt 1, R I Shader 1
PMCID: PMC1917851  PMID: 1964820

Abstract

1. Chronic benzodiazepine administration has been associated with tolerance and with downregulation of gamma-aminobutyric acidA (GABAA)-receptor binding and function. However, effects of individual benzodiazepines on brain regions have varied. 2. To compare the effects of chronic lorazepam and alprazolam, we have administered these drugs to mice for 1 and 7 days (2 mg kg-1 day-1) and determined benzodiazepine receptor binding in vivo with and without administration of CL 218,872, 25 mg kg-1 i.p., and GABA-dependent chloride uptake in 3 brain regions at these time points. 3. Benzodiazepine binding was decreased in the cortex and hippocampus at day 7 compared to day 1 of lorazepam, with an increase in CL 218,872-resistant (Type 2) sites in both regions. Maximal GABA-dependent chloride uptake was also decreased in the cortex and hippocampus at day 7. 4. Binding was decreased only in the cortex after 7 days of alprazolam, with no significant change in Type 2 binding. Maximal GABA-dependent chloride uptake was also decreased only in the cortex. 5. These data suggest that the effects of chronic benzodiazepine administration on the GABAA-receptor may be both region-specific and receptor subtype-specific.

Full text

PDF
839

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Garratt J. C., Gent J. P., Feely M., Haigh J. R. Can benzodiazepines be classified by characterising their anticonvulsant tolerance-inducing potential? Eur J Pharmacol. 1988 Jan 5;145(1):75–80. doi: 10.1016/0014-2999(88)90351-2. [DOI] [PubMed] [Google Scholar]
  2. Greenblatt D. J., Shader R. I. Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerations. Drug Metab Rev. 1978;8(1):13–28. doi: 10.3109/03602537808993775. [DOI] [PubMed] [Google Scholar]
  3. Lopez F., Miller L. G., Greenblatt D. J., Chesley S., Schatzki A., Shader R. I. Chronic administration of benzodiazepines--V. Rapid onset of behavioral and neurochemical alterations after discontinuation of alprazolam. Neuropharmacology. 1990 Mar;29(3):237–241. doi: 10.1016/0028-3908(90)90007-e. [DOI] [PubMed] [Google Scholar]
  4. Lopez F., Miller L. G., Greenblatt D. J., Kaplan G. B., Shader R. I. Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding. Eur J Pharmacol. 1989 Dec 5;172(6):453–459. doi: 10.1016/0922-4106(89)90028-x. [DOI] [PubMed] [Google Scholar]
  5. Lopez F., Miller L. G., Thompson M. L., Schatzki A., Chesley S., Greenblatt D. J., Shader R. I. Chronic morphine administration augments benzodiazepine binding and GABAA receptor function. Psychopharmacology (Berl) 1990;101(4):545–549. doi: 10.1007/BF02244235. [DOI] [PubMed] [Google Scholar]
  6. Marley R. J., Gallager D. W. Chronic diazepam treatment produces regionally specific changes in GABA-stimulated chloride influx. Eur J Pharmacol. 1989 Jan 17;159(3):217–223. doi: 10.1016/0014-2999(89)90151-9. [DOI] [PubMed] [Google Scholar]
  7. Miller L. G., Greenblatt D. J., Barnhill J. G., Shader R. I. Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function. J Pharmacol Exp Ther. 1988 Jul;246(1):170–176. [PubMed] [Google Scholar]
  8. Miller L. G., Greenblatt D. J., Roy R. B., Gaver A., Lopez F., Shader R. I. Chronic benzodiazepine administration. III. Upregulation of gamma-aminobutyric acidA receptor binding and function associated with chronic benzodiazepine antagonist administration. J Pharmacol Exp Ther. 1989 Mar;248(3):1096–1101. [PubMed] [Google Scholar]
  9. Miller L. G., Greenblatt D. J., Roy R. B., Summer W. R., Shader R. I. Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function. J Pharmacol Exp Ther. 1988 Jul;246(1):177–182. [PubMed] [Google Scholar]
  10. Miller L. G., Woolverton S., Greenblatt D. J., Lopez F., Roy R. B., Shader R. I. Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration. Biochem Pharmacol. 1989 Nov 1;38(21):3773–3777. doi: 10.1016/0006-2952(89)90584-4. [DOI] [PubMed] [Google Scholar]
  11. Olsen R. W., Tobin A. J. Molecular biology of GABAA receptors. FASEB J. 1990 Mar;4(5):1469–1480. doi: 10.1096/fasebj.4.5.2155149. [DOI] [PubMed] [Google Scholar]
  12. Pritchett D. B., Lüddens H., Seeburg P. H. Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. Science. 1989 Sep 22;245(4924):1389–1392. doi: 10.1126/science.2551039. [DOI] [PubMed] [Google Scholar]
  13. Sato T. N., Neale J. H. Type I and type II gamma-aminobutyric acid/benzodiazepine receptors: purification and analysis of novel receptor complex from neonatal cortex. J Neurochem. 1989 Apr;52(4):1114–1122. doi: 10.1111/j.1471-4159.1989.tb01855.x. [DOI] [PubMed] [Google Scholar]
  14. Schofield P. R., Shivers B. D., Seeburg P. H. The role of receptor subtype diversity in the CNS. Trends Neurosci. 1990 Jan;13(1):8–11. doi: 10.1016/0166-2236(90)90052-c. [DOI] [PubMed] [Google Scholar]
  15. Shivers B. D., Killisch I., Sprengel R., Sontheimer H., Köhler M., Schofield P. R., Seeburg P. H. Two novel GABAA receptor subunits exist in distinct neuronal subpopulations. Neuron. 1989 Sep;3(3):327–337. doi: 10.1016/0896-6273(89)90257-2. [DOI] [PubMed] [Google Scholar]
  16. Sieghart W. Multiplicity of GABAA--benzodiazepine receptors. Trends Pharmacol Sci. 1989 Oct;10(10):407–411. doi: 10.1016/0165-6147(89)90189-2. [DOI] [PubMed] [Google Scholar]
  17. Tietz E. I., Rosenberg H. C., Chiu T. H. Autoradiographic localization of benzodiazepine receptor downregulation. J Pharmacol Exp Ther. 1986 Jan;236(1):284–292. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES